Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Structure-activity relationship studies and design of a PTPN22 inhibitor with enhanced isozyme selectivity and cellular efficacy

European Journal of Medicinal Chemistry(2024)10.1016/j.ejmech.2024.117129Source: DataRank Database

Structure-activity relationship studies and design of a PTPN22 inhibitor with enhanced isozyme selectivity and cellular efficacy is a research paper published in European Journal of Medicinal Chemistry (2024). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

BindingDB Entry 50022736: Structure-activity relationship studies and design of a PTPN22 inhibitor with enhanced isozyme selectivity and cellular efficacy. · BindingDB

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: greenTopics (13)Linked Datasets (1)DataCite Reuse (1)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Yunpeng Bai ORCID,Zihan Qu ORCID,C. Sander,Jianping Lin ORCID,Jinmin Miao ORCID

Live enrichment

PubMed:39693863 PMC:PMC11709133

National Institutes of Health

Grant: RO1CA069202

NCI NIH HHS

Grant: R01 CA069202

Purdue Institute for Drug Discovery

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11709133/

publisherhttps://api.elsevier.com/content/article/PII:S0223523424010110?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0223523424010110?httpAccept=text/plain

repositoryhttps://doi.org/10.7270/q2n302sp

MeSH Terms

HumansIsoenzymesEnzyme InhibitorsMolecular StructureStructure-Activity RelationshipDose-Response Relationship, DrugDrug DesignModels, MolecularProtein Tyrosine Phosphatase, Non-Receptor Type 22

Keywords

Cancer ImmunotherapyPtpn22LypPtpn22 Inhibitors

BindingDB Entry 50022736: Structure-activity relationship studies and design of a PTPN22 inhibitor with enhanced isozyme selectivity and cellular efficacy.

10.7270/q2n302spBindingDB

Structure-activity relationship studies and design of a PTPN22 inhibitor with enhanced isozyme selectivity and cellular efficacy

FAIR Checklist

Authors (7)

Funding (3 grants)

Open Access

Topics

Linked Datasets (1)

Annotations (Europe PMC)